NVAX - Novavax, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue15,35336,25030,659
Cost of Revenue---
Gross Profit15,35336,25030,659
Operating Expenses
Research Development237,939162,64494,422
Selling General and Administrative46,52730,84219,928
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-269,113-157,236-83,691
Income from Continuing Operations
Total Other Income/Expenses Net2,112540901
Earnings Before Interest and Taxes-267,001-156,696-82,790
Interest Expense12,965241157
Income Before Tax-279,966-156,937-82,947
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-279,966-156,937-82,947
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-279,966-156,937-82,947
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-279,966-156,937-82,947